This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.

CME eReport

How to Evaluate Patients for Tardive Dyskinesia

Andrew A. Nierenberg, MD

Published: December 1, 2020

Tardive dyskinesia (TD) is a serious and potentially irreversible movement disorder that occurs in 20%–50% of patients taking antipsychotic drugs. TD is also associated with several other classes of medications, including antidepressants, antihistamines, decongestants, mood stabilizers, and stimulants. As more people are prescribed medications that can increase the risk for TD, it is important that clinicians learn how to systematically and reasonably evaluate their patients for this potentially dangerous and debilitating condition.

To cite: Nierenberg AA. How to evaluate patients for tardive dyskinesia. J Clin Psychiatry. 2021;82(1):NU19047BR1C.
To share:

© Copyright 2020 Physicians Postgraduate Press, Inc.

From the Bipolar Clinic and Research Program and the Depression Clinic and Research Program, Massachusetts General Hospital; and Department of Psychiatry, Harvard Medical School, Boston.

See the entire activity

Volume: 82

Quick Links: Psychiatry , Tardive Dyskinesia


Sign-up to stay
up-to-date today!


Already registered? Sign In

Original Research

Young-Adult Social Outcomes of Attention-Deficit/Hyperactivity Disorder

ADHD that persisted into young-adulthood was associated with poorer outcomes in terms of education, employment, and emotional...